2022 •
An Anti-Carcinogenic Formulation Composed of Cyclin D2 & HiF & MMP-9 Suppressive and Caspase 3-9 Activating Protopanaxatriol Class Glucopyranoside Analouges
Authors: Alkoclar, Erdal
Venue: N/A
Type: Publication
Abstract: A Protopanaxatriol class Glucopyranosides Consisting Anti- Cancer Formulation with Malignant Tumor Suppressive Features via Inhibiting HiF & Cyclin D2 & MMP-9 Expression and Elevating Caspase 3&9 Activity. MIT Bioceutical Innovations Articles by Erdal Can Alkoclar & Metehan Yeşil
We have placed cookies on your device to help make this website and the services we offer better. By using this site, you agree to the use of cookies. Learn more